Skip to main content

August 2014 Vol 7, Special Issue ASCO 2014 Payers' Perspectives in Oncology

FDA Approvals
Ramucirumab First Drug for Advanced Stomach Cancer
Read More
FDA Approvals
Ofatumumab Approved for Patients with CLL
Read More
FDA Approvals
Ibrutinib Approved for CLL
Read More
FDA Approvals
First Drug Combination Approved for Unresectable or Metastatic Melanoma
Read More
Site of Service Influences Value
Caroline Helwick
Read More
Value-Based Insurance Not Such an Easy Sell
Caroline Helwick
Read More
What Makes a Treatment Clinically Meaningful?
Caroline Helwick
Read More
ASCO Beginning to Address Value in Oncology
Caroline Helwick
Read More
Lung Cancer, Oncology
Ramucirumab Shows Survival Benefit in NSCLC
Caroline Helwick
Read More
Federal Spending on Cancer Research and Access to Care Woefully Inadequate
Wayne Kuznar
Read More
Page 2 of 4
Results 11 - 20 of 32